Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Healthcare Technology Assessments

HARMONY Alliance: 3rd General Assembly for Partners and Associated Members

Published: 26 Nov 2018

Views: 1050

Rating:

Save

Prof Andrea Manca - University of York, UK, HARMONY Partner

Prof Andrea Manca speaks with ecancer at the HARMONY Project general assembly 2018 in Valencia.

He gives an overview of HTAs, or Healthcare Technology Assessments.

To see more from HARMONY visit their website.

Related Videos

Tele-mentoring: Impact of project ECHO

Dr Sanjeev Arora - Project ECHO, Albuquerque, USA

Tele-mentoring: Impact of project ECHO ( Dr Sanjeev Arora - Project ECHO, Albuquerque, USA )

Genetic testing and targeted therapy in Ivory Coast

Dr Safiatou Coulibaly - Institute Pasteur De Côte D'ivoire, Adiopodoumé, Ivory...

Genetic testing and targeted therapy in Ivory Coast ( Dr Safiatou Coulibaly - Institute Pasteur De Côte D'ivoire, Adiopodoumé, Ivory Coast )

Synthetic biology and precision medicine in blood and gynaecological cancers

Dr Mutsa Takundwa - Council for Scientific and Industrial Research, Pretoria...

Synthetic biology and precision medicine in blood and gynaecological cancers ( Dr Mutsa Takundwa - Council for Scientific and Industrial Research, Pretoria, South Africa )

Introducing oncology to undergraduate medical and allied health sciences...

Dr Soumitra Shankar Datta - Tata Medical Center, Kolkata, India

Introducing oncology to undergraduate medical and allied health sciences students ( Dr Soumitra Shankar Datta - Tata Medical Center, Kolkata, India )

Patient benefit vs industry benefit finding a balance

Dr Bishal Gyawali - Queen's University, Kingston, Canada

Patient benefit vs industry benefit finding a balance ( Dr Bishal Gyawali - Queen's University, Kingston, Canada )

Adagrasib shows durable clinical benefit in advanced KRAS-mutant NSCLC

Dr Shirish Gadgeel - Henry Ford Cancer Institute, Detroit, USA

Adagrasib shows durable clinical benefit in advanced KRAS-mutant NSCLC ( Dr Shirish Gadgeel - Henry Ford Cancer Institute, Detroit, USA )

OncoAlert Round Up for September 15-21, 2023

Dr Gil Morgan - Executive Director, OncoAlert

OncoAlert Round Up for September 15-21, 2023 ( Dr Gil Morgan - Executive Director, OncoAlert )

ASCO's efforts to improve global cancer care through the years

Dr Carlos Santiago Vallejos Sologuren - Oncosalud, Lima, Peru

ASCO's efforts to improve global cancer care through the years ( Dr Carlos Santiago Vallejos Sologuren - Oncosalud, Lima, Peru )

The use of IORT at Universitätsmedizin Mannheim hospital

Dr Elena Sperk - Universitätsmedizin Mannheim, Mannheim, Germany

The use of IORT at Universitätsmedizin Mannheim hospital ( Dr Elena Sperk - Universitätsmedizin Mannheim, Mannheim, Germany )

More from ecancer